
|Articles|November 20, 2007
Matthew Kurtz
Advertisement
Matthew Kurtz, Regional Sales Manager
T: (212) 951-6751
F: (212) 951-6604
Covers New York, New Jersey, and international outside Canada
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5




